OcuHist
Company: PfizerApproval Status: Approved January 1996
Treatment for: itching and redness of the eye
Areas: Eye Health / Ophthalmology; Respiratory
| General Information | Additional Information |
General Information
OcuHist has been approved as an over-the-counter antihistamine eye drop. Akorn, previously marketed this formulation as the prescription drug AK-Con-A.
With its active antihistamine ingredient pheniramine maleate (0.3%), and decongestant ingredient naphazoline hydrochloride (0.025%), OcuHist temporarily relieves itching and redness of the eye due to pollen, ragweed, grass, animal hair, and dander.
Additional Information
An estimated 50 million Americans are afflicted by pollen, ragweed, and other irritants.
OcuHist Drug Information
The Ocuhist drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
